Sorry, you need to enable JavaScript to visit this website.

Tate & Lyle and McNeil Nutritionals Announce Global Sucralose Alliance

| Filed in:
Tate & Lyle PLC (‘Tate & Lyle’) and McNeil Nutritionals (‘McNeil’), a Johnson & Johnson company, announced today the realignment of their sucralose activities into a new global alliance designed to maximize the market penetration and accelerate the worldwide growth of sucralose. Existing sucralose sales and marketing arrangements have been restructured to play to the geographic and market strengths of each company.

Under the agreement, the companies will co-operate closely to further the development of the sucralose business. Tate & Lyle will act as exclusive broker for sucralose ingredient sales in certain key markets outside of North America. McNeil will exclusively market the Splenda® tabletop brand of sucralose to retailers worldwide.

The formation of this alliance represents a continuance of the 20-year partnership between the two companies. Sucralose, a non-caloric sweetener made from sugar, is manufactured by McNeil in the United States, and is currently approved in over 40 countries worldwide.

Larry Pillard, Chief Executive of Tate & Lyle said:
‘We are glad to be able to further our long-standing relationship with McNeil through this alliance. The new arrangements will enable us to leverage our global sales network and offer this exciting product to more of our customers alongside our existing range of value added carbohydrate-based food ingredients and sweeteners.’

Click here for our press image gallery

About Tate & Lyle: 
Tate & Lyle is a world leader in ingredient solutions for healthier food and beverages. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fortification, we develop solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.

We have more than 3,500 employees working in around 60 locations across 39 countries. Tate & Lyle's purpose is Transforming Lives Through the Science of Food and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2022, Tate & Lyle revenue from continuing operations totalled £1.4 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on TwitterLinkedin or Facebook.